Keto lactam compounds and use thereof
    53.
    发明授权
    Keto lactam compounds and use thereof 有权
    酮内酰胺化合物及其用途

    公开(公告)号:US07723384B2

    公开(公告)日:2010-05-25

    申请号:US10582285

    申请日:2004-12-10

    摘要: The invention relates to novel keto lactam compounds, hydrogenated derivatives and tautomers thereof. These compounds have valuable therapeutic properties and are particularly suited for treating diseases that respond to the modulation of the dopamine D3 receptor. The keto lactams have general formula (I), wherein: (a) represents a group of formulas (b) or (c), wherein D is bound to the nitrogen atom and W, Rp and Rq have the meanings cited in Claim 1; —B— represents a bond or (d), wherein Rm and Rn have the meanings cited in Claim 1; (e) represents a single bond or a double bond; Rv, Rw, Rx and Ry have the meanings cited in Claim 1; D represents a linear or branched 2 to 10-membered alkylene chain that can have, as chain members, a heteroatom group K, which is selected among O, S, S(O), S(O)2, N—R8, CO—O, C(O)NR8 and/or 1 or 2 non-adjacent carbonyl groups and which can have a cycloalkane diyl group and/or a double or triple bond; (f) represents a saturated or monounsaturated monocyclic nitrogen heterocyclic compound having 5 to 8 cyclic members or a bicyclic saturated nitrogen heterocyclic compound having 7 to 12 cyclic members.

    摘要翻译: 本发明涉及新型酮内酰胺化合物,氢化衍生物及其互变异构体。 这些化合物具有有价值的治疗特性,特别适用于治疗对多巴胺D3受体调节作出反应的疾病。 酮内酰胺具有通式(I),其中:(a)表示式(b)或(c)中的基团,其中D与氮原子结合,W,Rp和Rq具有权利要求1所述的含义; -B-表示键或(d),其中Rm和Rn具有权利要求1中引用的含义; (e)表示单键或双键; Rv,Rw,Rx和Ry具有权利要求1中引用的含义; D表示可以具有作为链成员的选自O,S,S(O),S(O)2,N-R8,CO(C 1 -C 6)中的杂原子基团K的直链或支链2至10元亚烷基链 -O,C(O)NR 8和/或1或2个不相邻的羰基,并且其可具有环烷烃二基和/或双键或三键; (f)表示具有5〜8个环状成员的饱和或单不饱和单环氮杂环化合物或具有7〜12个环状成员的双环饱和氮杂环化合物。